RE:RE:There is a special place in HellRat experiment= half truth. They just finished a Ph1b with TLD 1433 on very ill human patients to verify safety and unfortunately, turns out that on top of being extremely safe, they got no more cancer...
No guidance= full bs. They said that as the successful Ph1 trial is now over ( shortened cause of tremendous results), they will draft up a Ph2 protocol and apply for it.
Market says... and??= half truth. Market is indeed watching and waiting. Time could not be sped up like a taped TV show. Better to make the steps the right way than botch everything up. Takes time you can’t deny that. As they hit the milestones, which they have, the market will react accordingly. Market is not biased for or against TLT, they are in it just like you and me, to make a buck!!
That is just 3 in a very short paragraph. Continue writing, I’ll find more.
GLTA